Williams D., Park L.: Hematopoietic effects of a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein. Cancer67:2705-2707, 1991
2.
Curtis B., Williams D., Broxmeyer H., et al: Enhanced hematopoietic activity of a human granulocyte-macrophage colony stimulating factor-interleukin-3 fusion protein. Proc National Academy Science USA 88:5809-5813, 1991
3.
Donahue R., SeeharJ, Metzger M., et al: Human IL-3 and GM-CSF act synergistically in stimulating hematopoiesis in primates. Science241:1820-1823, 1988
4.
Ganser A., Lindemann A. Seipelt G, et al: Synergistic effects of sequential IL-3/GM-CSF treatment in comparison to IL-3 alone in vivo. Blood76:145, 1990
5.
Bot F., Dorssers L., Wagenmaker G., et al: Stimulating spectrum of human recombinant multi-CSF (IL-3) on human marrow precursors: Importance of accessory cells. Blood71:1609-1614, 1988
6.
Cairo M., Law P., Van de Ven C., et al: The in vitro effects of stem cell factors and PIXY 321 on myeloid progenitor formation (CFU-GM) form immunomagnetic separated CD34+ cord blood . Pediatric Res32:277-281, 1992
7.
Briddell R., Brandt J., Leemhuis T., et al: Role of cytokines in sustaining long-term human megakaryocytopoiesis in vitro. Blood79:332-337, 1992
8.
Extrov Z., Kurzrock R., Taipaz M., et al: Granulocyte-macrophage colony-stimulating factor and interleukin-3 in combination: A potent and consistent myelodysplastic syndrome bone marrow stimulant in vitro. Blood76:267, 1990
9.
National Cancer Institute: PIXY 321. National Cancer Institute, 1992
